$ORIC
Oric Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
ORIC chart
What traders are saying about $ORIC
Latest postsOric Pharmaceuticals, Inc. news
- ORIC Pharmaceuticals at guggenheim healthcare conference: late-stage push By Investing.com
Investing.com Canada ·
- Oric Pharmaceuticals, Inc. $ORIC Stock Sold by Candriam S.C.A.
MarketBeat ·
- ORIC Pharmaceuticals Inc. R (4TZ.HM) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- ORIC Pharmaceuticals, Inc. (ORIC) stock price, news, quote and history
Yahoo Finance Singapore ·
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Oric Pharmaceuticals (ORIC) Set to Post Quarterly Earnings on Thursday
MarketBeat ·
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- ORIC Pharmaceuticals (ORIC) Stock Sees Modest Fair Value Lift On Trial Catalyst Optimism
Yahoo Finance ·
- ORIC Pharmaceuticals Sinks 22% as J&J Presents Rival Prostate Cancer Data
tikr.com ·
- Oric Pharmaceuticals’ Enozertinib Shows 88% Response Rate in EGFR Lung Cancer Study
marketbeat.com ·
- ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026
Yahoo Finance ·
- ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial
Yahoo Finance ·
Oric Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$129.5M | -$127.8M | -$100.7M | -$89.1M |
| Diluted EPS | $-1.47 | $-1.83 | $-1.96 | $-2.25 |
| Total assets (year end) | $408.9M | $274.1M | $252.0M | $247.2M |
| Cash and equivalents (year end) | $45.7M | $59.4M | $23.4M | $66.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Oric Pharmaceuticals, Inc.
- Ticker
- ORIC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1796280
Frequently asked questions
What exchange is Oric Pharmaceuticals, Inc. listed on?
Oric Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ORIC.
What industry is Oric Pharmaceuticals, Inc. in?
Oric Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Oric Pharmaceuticals, Inc. headquartered?
Oric Pharmaceuticals, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Oric Pharmaceuticals, Inc.'s fiscal year end?
Oric Pharmaceuticals, Inc.'s fiscal year ends on December 31.